新型长链非编码RNA HEAT4影响单核细胞亚型并促进血管愈合
该研究通过单细胞测序发现人特异性长链非编码RNA HEAT4,在心力衰竭、急性心肌梗死或心源性休克患者血液中表达升高。HEAT4由IL-10转录激活,通过结合S100A9促使单核细胞向抗炎CD16+亚型转化,减少炎症并改善小鼠血管损伤后的愈合。HEAT4水平可区分心衰患者并预测7年全因死亡。
要点
- HEAT4在HF、AMI或心源性休克患者血液中表达升高,可区分HF患者并预测7年全因死亡。
- HEAT4由IL-10转录激活,通过结合S100A9促使单核细胞向抗炎CD16+亚型转化。
- HEAT4改善炎症时内皮屏障完整性并促进小鼠血管损伤后愈合。
核心结论
- HEAT4是一种内源性抗炎通路,通过将单核细胞转化为抗炎CD16+亚型来减少炎症并促进血管愈合。
研究设计与样本
- 研究采用外周血单个核细胞单细胞测序发现HEAT4,并在多种体外和离体免疫细胞活化模型及HF、AMI、心源性休克患者血液中评估表达。
- 通过功能获得和缺失研究及多种RNA-蛋白相互作用实验揭示机制,并在NOD.CB17-Prkdc scid/Rj小鼠血管损伤模型中表征HEAT4表达和功能。
主要发现
- HEAT4在HF、急性心肌梗死或心源性休克患者血液中表达增加。
- HEAT4水平可区分HF患者与非HF者,并在HF患者队列中预测7年随访全因死亡。
- 单核细胞尤其是抗炎CD16+单核细胞是血液中HEAT4的主要来源,且CD16+单核细胞在HF患者中增加。
- HEAT4由抗炎白介素-10转录激活,激活抗炎基因并抑制促炎基因表达。
- HEAT4结合S100A9导致单核细胞亚型转换,减少炎症,改善内皮屏障完整性并促进小鼠血管损伤后愈合。
临床怎么用
- HEAT4水平有望作为HF患者的预后标志物,用于风险分层。
- 靶向HEAT4通路可能成为心血管免疫学领域的干预策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Activation of the immune system contributes to cardiovascular diseases. The role of human-specific long noncoding RNAs in cardioimmunology is poorly understood. METHODS: Single-cell sequencing in peripheral blood mononuclear cells revealed a novel human-specific long noncoding RNA called HEAT4 (heart failure-associated transcript 4). HEAT4 expression was assessed in several in vitro and ex vivo models of immune cell activation, as well as in the blood of patients with heart failure (HF), acute myocardial infarction, or cardiogenic shock. The transcriptional regulation of HEAT4 was verified through cytokine treatment and single-cell sequencing. Loss-of-function and gain-of-function studies and multiple RNA-protein interaction assays uncovered a mechanistic role of HEAT4 in the monocyte anti-inflammatory gene program. HEAT4 expression and function was characterized in a vascular injury model in NOD.CB17-Prkdc scid/Rj mice. RESULTS: HEAT4 expression was increased in the blood of patients with HF, acute myocardial infarction, or cardiogenic shock. HEAT4 levels distinguished patients with HF from people without HF and predicted all-cause mortality in a cohort of patients with HF over 7 years of follow-up. Monocytes, particularly anti-inflammatory CD16+ monocytes, which are increased in patients with HF, are the primary source of HEAT4 expression in the blood. HEAT4 is transcriptionally activated by treatment with anti-inflammatory interleukin-10. HEAT4 activates anti-inflammatory and inhibits proinflammatory gene expression. Increased HEAT4 levels result in a shift toward more CD16+ monocytes. HEAT4 binds to S100A9, causing a monocyte subtype switch, thereby reducing inflammation. As a result, HEAT4 improves endothelial barrier integrity during inflammation and promotes vascular healing after injury in mice. CONCLUSIONS: These results characterize a novel endogenous anti-inflammatory pathway that involves the conversion of monocyte subtypes into anti-inflammatory CD16+ monocytes. The data identify a novel function for the class of long noncoding RNAs by preventing protein secretion and suggest long noncoding RNAs as potential targets for interventions in the field of cardioimmunology.
引用
- Kneuer, Grajek, Winkler, et al. Novel Long Noncoding RNA HEAT4 Affects Monocyte Subtypes, Reducing Inflammation and Promoting Vascular Healing. Circulation. 2024. PMID: 39005211. doi:10.1161/CIRCULATIONAHA.124.069315
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。